Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 32.52
-0.16 (-0.49%)
Oct 8, 2025, 4:13 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.70 billion as of October 8, 2025. Its market cap has increased by 2.75% in one year.
Market Cap
4.70B
Enterprise Value
5.59B
Revenue
3.06B
Ranking
n/a
PE Ratio
30.83
Stock Price
32.52
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.70B, a decrease of -6.00%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 4.70B | -4.02% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | 4.47B | 18.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 99.44B |
| Pro Medicus | 31.79B |
| Cochlear | 18.63B |
| Sonic Healthcare | 10.70B |
| Ramsay Health Care | 7.30B |
| Telix Pharmaceuticals | 5.18B |
| Mesoblast | 3.32B |
| Neuren Pharmaceuticals | 2.71B |